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RyR2/IRBIT regulates insulin
gene transcript, insulin content,
and secretion in the insulinoma cell
line INS‑1
Kyle E. Harvey1,5, Emily K. LaVigne1,2,5, Mohd Saleem Dar4, Amy E. Salyer1,
Evan P. S. Pratt1,2, Paxton A. Sample1, Uma K. Aryal3, Humaira Gowher4 &
Gregory H. Hockerman1*
The role of ER Ca2+ release via ryanodine receptors (RyR) in pancreatic β-cell function is not well
defined. Deletion of RyR2 from the rat insulinoma INS-1 (RyR2KO) enhanced IP3 receptor activity
stimulated by 7.5 mM glucose, coincident with reduced levels of the protein IP3 Receptor Binding
protein released with Inositol 1,4,5 Trisphosphate (IRBIT). Insulin content, basal (2.5 mM glucose) and
7.5 mM glucose-stimulated insulin secretion were reduced in RyR2KO and IRBITKO cells compared to
controls. INS2 mRNA levels were reduced in both RyR2KO and IRBITKO cells, but INS1 mRNA levels were
specifically decreased in RyR2KO cells. Nuclear localization of S-adenosylhomocysteinase (AHCY) was
increased in RyR2KO and IRBITKO cells. DNA methylation of the INS1 and INS2 gene promotor regions
was very low, and not different among RyR2KO, IRBITKO, and controls, but exon 2 of the INS1 and INS2
genes was more extensively methylated in RyR2KO and IRBITKO cells. Exploratory proteomic analysis
revealed that deletion of RyR2 or IRBIT resulted in differential regulation of 314 and 137 proteins,
respectively, with 41 in common. These results suggest that RyR2 regulates IRBIT levels and activity in
INS-1 cells, and together maintain insulin content and secretion, and regulate the proteome, perhaps
via DNA methylation.
Ca2+ signaling plays an essential role in pancreatic β-cell function and pathophysiology, and involves both C
 a2+
influx into the cell via plasma membrane Ca2+ channels, and efflux of Ca2+ from the endoplasmic reticulum
(ER) through ER membrane Ca2+ channels1. Voltage-gated Ca2+ channels Cav1.2, Cav1.3, and Cav2.1 are located
on the plasma membrane, and are key players in nutrient-stimulated insulin secretion2 and in regulation of
pancreatic β-cell proliferation3. The roles for the ER membrane C
 a2+ channels ryanodine receptor 2 (RyR2)
and inositol 1,4,5-triphosphate receptor (IP3R) are less well defined in β-cells. Pharmacological studies initially
suggested a role for RyRs in β-cells4. Subsequently, RyR2 was detected in the INS-1 cell line and murine β-cells,
and it was demonstrated that ER stress affects RyR2 f unction5. In addition, efflux of C
 a2+ from the ER from
both RyR and I P3R accelerate apoptosis in response to ER stress in the MIN6 cell line and mouse islet c ells6.
Cav1.2 activity is proposed to couple to RyR activation in INS-1 cells via Ca2+-induced Ca2+ release (CICR)7.
RyR2 is detected in human β-cells8,9, and RyR2 activity protects human β-cells from apoptosis by suppressing
calpain 10 e xpression10. Mutations in human RyR2 that cause Ca2+ “leak” induce both cardiac arrhythmias and
glucose intolerance, and introduction of the corresponding mutations in mice led to glucose intolerance and a
phenotype similar to type 2 diabetes11. A mutation in RyR2 mimicking CaMKII phosphorylation leads to basal
hyperinsulinemia and glucose intolerance, both ascribed to increased leak of Ca2+ from the ER via RyR212. The
major IP3R expressed in human β-cells is IP3R39,13. Animal studies support a role for IP3R3 in glucose-stimulated
insulin secretion14, and IP3 receptors play a role in cholinergic regulation of insulin secretion15. Both IP3R and
RyR2 are C
 a2+-activated ion channels that mediate release of C
 a2+ of the ER, and regulate each other’s activity
2+
16
via Ca -dependent mechanisms .
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Figure 1.  Characterization of RyR2KO cells (a) Aligned genomic DNA sequences (exon 6) of the rat RYR2 gene
in control and two distinct clones. Sequencing confirmed insertion of an indel (underlined/bolded) leading to a
frameshift mutation (bolded) and a premature stop codon (red bolded). (b) Preliminary screen (representative
of 3 independent experiments) showing caffeine (5 mM) mobilization of C
 a2+ in control INS-1 and an RyR2KO
clone measured with fura-2 AM using a 96-well plate format. Data are shown as mean ± SD. (c) Representative
experiments showing single-cell imaging of Ca2+ transients measured using fura-2 AM. RyR2KO cells are
insensitive to stimulation with the RyR2 agonist caffeine (5 mM), whereas caffeine elicits a rapid C
 a2+ transient
in INS-1 cells. Both cell lines display a robust Ca2+ transient in response to the muscarinic agonist carbachol
(500 μM). (d) Quantitation of the C
 a2+ response (AUC) to 5 mM caffeine in KRBH in control INS-1 and RyR2KO
cells. Lines represent mean ± SD ****P < 0.0001, unpaired t-test; n = 38 cells (INS-1) and 39 cells ( RyR2KO) from
3 independent experiments. (e) Immunoblots for RyR from control and RyR2KO cells. The total protein loaded
in each lane (μg) is indicated. Samples were probed with a pan-specific RyR antibody. As a positive control,
recombinant mouse RyR2 fused to GFP and expressed in HEK 293 T cells was included. As a loading control,
membranes were also probed with an antibody to the α1 subunit of the Na+/K+-Atpase (Atp1A1). Immunoblots
shown are representative of 4 independent experiments. (f) Basal C
 a2+ levels in control INS-1 and RyR2KO
cells measured with fura-2 AM in KRBH. ***P < 0.001; unpaired t-test, n = 12 (control and RyR2KO) over 3
independent experiments. Lines represent mean ± SD.

Crosstalk between RyR2 and I P3R receptors may play a role in regulation of β-cell f unction12. One potential
link in this crosstalk may be the regulation of the IP3 receptor binding protein IP3 Receptor Binding protein
released with Inositol 1,4,5 Trisphosphate (IRBIT; a.k.a. AHCYL1). IRBIT binds to IP3 receptors in a manner
competitive with I P3 and thus inhibits channel o
 pening17. IRBIT must be serially phosphorylated to bind I P3
receptors, and the first step is a Ca2+-dependent phosphorylation thought to be mediated by a member of the
Ca2+-calmodulin-dependent kinase family, possibly C
 aMKIV18, but protein kinase D can also phosphorylate
IRBIT in vitro19. Neither the mechanisms for activation of IRBIT in vivo, nor the role of IRBIT in pancreatic
β-cells is known.
In the present study, we investigated the role of RyR2 in pancreatic β-cell signaling by deleting RyR2 from
INS-1 cells using CRISPR-Cas9 gene editing20. We assessed the role of RyR2 in glucose stimulated Ca2+ transients, and found that RyR2 deletion increased the activity of IP3 receptors, co-incident with a marked decrease
in protein levels of IRBIT. We further probed the role of IRBIT in several phenotypes of RyR2KO cells by deleting IRBIT from INS-1 cells. Our results suggest that RyR2 regulates IRBIT activity, and together, they regulate
insulin production and secretion.

Results

Characterization of RyR2KO cells. Pancreatic β-cells potentially express RyR1, RyR2, and RyR3, but we
chose to delete RyR2 in INS-1 cells given the previously reported effects of RyR2 mutations on glycemic control
in both h
 umans11 and m
 ice12. We used CRISPR-Cas9 gene editing, with two distinct guide RNAs, to introduce indels in exon 6 of the rat RyR2 gene in INS-1 cells that generated premature stop codons as assessed by
sequencing genomic DNA (Fig. 1a). Positive clones were identified by screening for loss of caffeine (5 mM)
stimulation of RyR-mediated Ca2+ release from the ER in a 96-well format, using fura-2 AM (Fig. 1b). SingleScientific Reports |
Vol:.(1234567890)
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cell Ca2+ measurements using fura-2 AM confirmed the loss of caffeine sensitivity in RyR2 knock out ( RyR2KO)
cells (Fig. 1c); however, these cells displayed a strong increase in [ Ca2+]in in response to the muscarinic agonist
carbachol (500 µM) (Fig. 1c), suggesting that I P3 receptor activity is intact. Analysis of single-cell C
 a2+ imaging
experiments showed that the Ca2+ response (AUC) to caffeine was reduced by > 90% in RyR2KO cells, compared
to control INS-1 cells (Fig. 1d). The absence of RyR2 protein in R
 yR2KO cells was confirmed by immunoblotting of microsomal proteins from control and RyR2KO INS-1 cells and HEK 293 cells transfected with mouse
RyR2-GFP21 with a pan-specific RyR antibody (Fig. 1e). Finally, basal (2.5 mM glucose) cytoplasmic C
 a2+ levels
as measured with fura-2 AM were slightly lower in R
 yR2KO cells compared to controls (Fig. 1f), suggesting that
RyR2 contributes to basal cytoplasmic Ca2+ levels.

Ca2+ dynamics in RyR2KO cells.

Stimulation of both control INS-1 and RyR2KO cells with 7.5 mM glucose
resulted in periodic [Ca ]in oscillations (Fig. 2a). The Ca2+ integral was inhibited in both cell lines by 2 µM nicardipine; however, the total AUC in the absence of nicardipine was greater in RyR2KO cells compared to control
cells (Fig. 2b). The C
 a2+ response to 7.5 mM glucose was inhibited by 1 µM xestospongin C (xesto) in R
 yR2KO
cells but not in controls (Fig. 2c–e). Xesto also increased the time between peaks in R
 yR2KO cells (Fig. 2f), but
reduced the time between peaks in control INS-1 cells (Fig. 2f). Thus, I P3 receptors are major contributors to
glucose-stimulated Ca2+ oscillations in RyR2KO cells, but not in control INS-1 cells.
2+

Regulation of IRBIT by RyR2. Given the apparent increase in IP3 receptor activation in response to glucose that we observed in RyR2KO cells, we examined the ability of glucose to activate phospholipase C (PLC) in
both RyR2KO and INS-1 cells. Stimulation with 7.5 mM glucose (Fig. 3a) or 500 µM of the muscarinic receptor
agonist carbachol (Fig. 3b) stimulated PLC activity above basal levels in both control and RyR2KO cells. However, stimulated PLC activity was decreased in RyR2KO cells compared to control INS-1 cells (Fig. 3c). Thus,
the increased IP3 receptor activity observed with glucose stimulation in RyR2KO cells is unlikely the result of
increased PLC activity and greater accumulation of I P3. Total cellular phosphatidylinositol bisphosphate ( PIP2)
levels in fixed, saponin-treated cells was measured using immunocytochemistry. R
 yR2KO cells contained slightly
more PIP2 than control INS-1 cells (Fig. 3d). Thus, the reduced PLC activity in RyR2KO cells is unlikely to be
the result of limiting substrate levels. Given these findings, we measured the levels of the protein IRBIT (aka
AHCYL1). Using semi-quantitative immunoblotting, we found that IRBIT protein levels normalized to actin,
were substantially reduced (~80% reduction) in RyR2KO cells compared to control cells (Fig. 3e). These data suggest that in the absence of RyR2, IRBIT protein levels/activity are suppressed, allowing hyperactivation of IP3Rs.
Characterization of IRBITKO cells.

To decipher which effects of RyR2 deletion are likely directly due to
loss of ER Ca2+ release via RyR2, and which are likely mediated by dysregulation of IRBIT, we deleted IRBIT
from INS-1 cells using CRISPR/cas9 gene editing with gRNAs targeted to exon 6 of the AHCYL1 gene. Genomic
DNA sequencing identified clones with expected indels (Fig. 4a). Immunoblots of cell lysates from IRBITKO
cells confirmed the absence of IRBIT protein (Fig. 4b). IRBIT mRNA was reduced in I RBITKO cells compared to
controls, but IRBIT mRNA wasn’t reduced in R
 yR2KO cells (Fig. 4c). Basal (2.5 mM glucose) [ Ca2+]in measured
with fura-2 AM was greater in I RBITKO cells compared to R
 yR2KO cells, but was not different from that measured
2+
in control INS-1 cells (Fig. 4d). The [Ca ]in response to 5 mM caffeine in I RBITKO cells, measured with fura-2
AM, was reduced compared to control INS-1 cells, but was much greater than that observed in RyR2KO cells
(Fig. 4e). Using the ER-targeted Ca2+ indicator D
 1ER22 to measure ER Ca2+ levels, we found that basal ER [Ca2+]
was reduced in I RBITKO cells compared to both R
 yR2KO and control INS-1 cells, and that thapsigargin treatment
2+
reduced ER [Ca ] to levels that were not different across the three cell lines (Fig. 4f). The [Ca2+]in response to
7.5 mM glucose in I RBITKO cells was inhibited by 1 µM xesto (Fig. 4g, h), and was greater than in control INS-1
cells, but not different from that measured in RyR2KO cells (Fig. 4i). Thus, abolition of the caffeine response in
RyR2KO cells is the direct result of the deletion of RyR2, but IRBIT is required to maintain the full magnitude of
RyR2-mediated Ca2+ release. In contrast, increased Ca2+ response to 7.5 mM glucose and block of this response
by xesto in R
 yR2KO cells is likely the result of reduced IRBIT levels.

Insulin content and secretion in RyR2KO and IRBITKO cells. Since [Ca2+]in is a key regulator of insulin
secretion, we measured insulin secretion in response to glucose in control INS-1, R
 yR2KO, and I RBITKO cells. We
examined glucose-stimulated insulin secretion (GSIS) at 2.5 mM and 7.5 mM glucose in all three cell lines, and
examined the contribution of L-type Ca2+ channels and I P3 receptors to GSIS. 2 µM nicardipine (L-type channel blocker) completely inhibited 7.5 mM GSIS in all three cell lines, but 1 µM xesto didn’t affect 7.5 mM GSIS
in any of the cell lines. In each case, nicardipine suppressed GSIS to a level not different from that stimulated by
2.5 mM glucose (Fig. 5a). Insulin secretion at both 2.5 mM and 7.5 mM glucose was reduced in both RyR2KO
and IRBITKO cells compared to controls (Fig. 5b). Insulin content was reduced ~ 70% in RyR2KO cells and ~ 40%
in IRBITKO cells compared to control INS-1 cells as measured by insulin assay of ethanol/HCl-extracted cells,
normalized to protein (Fig. 5c). ER C
 a2+ release contributes to glucose-dependent activation of extracellularsignal regulated protein kinase (ERK) 1/23, which phosphorylates and activates several transcription factors
involved in positive regulation of insulin transcription23. 7.5 mM glucose stimulated an ~ threefold increase in
pERK 1/2 compared to 2.5 mM glucose in control, R
 yR2KO, and I RBITKO cells (Fig. 5d). Glucagon-like peptide
1 (50 nM) potentiated pERK in the presence of 7.5 mM glucose in all three cell lines. Epidermal growth factor
(15 nM) potentiated pERK in the presence of 7.5 mM glucose in control and RyR2KO cells, but this potentiation
was abolished in IRBITKO cells (Fig. 5d). Thus, deficits in glucose-stimulated ERK 1/2 phosphorylation likely
don’t contribute to the decreased insulin content in RyR2KO or IRBITKO cells. However, levels of INS2 transcript
were markedly suppressed in both R
 yR2KO and I RBITKO cells compared to controls (Fig. 5e). In contrast, levels
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Figure 2.  Glucose-stimulated Ca2+ transients in INS-1 and R
 yR2KO cells (a) Single-cell Ca2+ transients
KO
measured in INS-1 and RyR2 cells in response to 7.5 mM glucose from a baseline of 0 mM glucose. (b)
Nicardipine (Nic; 2 μM) inhibited the Ca2+ AUC in INS-1 and RyR2KO INS-1 cells stimulated with 7.5 mM
glucose from a baseline of 0 mM glucose. Additionally, glucose-stimulated C
 a2+ AUC was increased in
RyR2KO INS-1 cells as compared to INS-1 cells. INS-1: glucose, n = 23 cells (5 independent experiments);
glucose + Nicardipine, n = 11 cells (5 independent experiments). RyR2KO: glucose, n = 39 cells (3 independent
experiments); glucose + nicardipine, n = 13 from 3 independent experiments (**P = 0.0022; ***P = 0.0003;
Students unpaired t-test glucose alone compared to glucose + nicardipine. **P = 0.0059; one-way ANOVA with
Tukey’s post-hoc test) INS-1 + glucose compared to RyR2KO + glucose. Lines represent mean ± SD. Representative
single-cell Ca2+ transients measured in INS-1 cells (c) and RyR2KO INS-1 cells (d) stimulated with glucose
from a baseline of 0 mM glucose in the presence or absence of xestospongin C (Xesto; 1 μM). (e) Xestospongin
C (Xest) significantly diminished the glucose-stimulated C
 a2+ AUC in RyR2KO INS-1 cells but had no effect
in INS-1 cells (*P < 0.0426) (two-way ANOVA with Sidak’s post-hoc test). INS-1: glucose, n = 23 cells (5
independent experiments); glucose + xest, n = 12 cells (3 independent experiments). RyR2KO: glucose, n = 19
cells (4 independent experiments); glucose + xest, n = 14 cells (3 independent experiments). Lines represent
mean ± SD. (f) The presence of xestospongin c reduced the time between glucose-stimulated C
 a2+ oscillations
(period) in INS-1 cells, while it significantly increased the period in R
 yR2KO INS-1 cells. Furthermore,
xestospongin c increased the period in R
 yR2KO INS-1 cells as compared to INS-1 cells ( ****P < 0.0001, *P = 0.011
(INS-1), *P = 0.015 (RyR2KO)) (two-way ANOVA with Tukey’s post-hoc test). INS-1: glucose, n = 159 peaks;
glucose + xest, n = 153 peaks in 5 independent experiments. R
 yR2KO: glucose, n = 160 peaks; glucose + xest, n = 62
peaks in 5 independent experiments). Lines represent mean ± SD.

of INS1 mRNA weren’t different from controls in I RBITKO cells, but were decreased in R
 yR2KO cells compared
to controls (Fig. 5e).

Regulation of AHCY localization by RyR2 and IRBIT. One potentially global effect of IRBIT deletion
is dysregulation of methyltransferase activity. IRBIT binds to S-adenosyl homocysteinase (AHCY)24,25, the only
enzyme known to hydrolyze S-adenosyl homocysteine (SAH) and relieve product inhibition of DNA, RNA, and
protein methyltransferases, and regulates nuclear localization of A
 HCY25. We examined the subcellular localiKO
KO
zation of AHCY in control, R
 yR2 , and IRBIT cells using immunocytochemistry. Confocal micrographs
Scientific Reports |
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Figure 3.  Phospholipase C activity in control INS-1 and R
 yR2KO cells-PLC activity was assessed by measuring
basal and stimulated IP1 levels (an indirect measure of IP3 levels) in (a) INS-1 and (b) RyR2KO INS-1 cells. 1 h
stimulation with 7.5 mM glucose (Gluc) or 500 μM carbachol (Carb;) resulted in increased I P1 accumulation
in control INS-1 cells compared to basal (A; ****P < 0.0001; One-way ANOVA, Dunnett’s post-hoc test (basal,
n = 16; Gluc, n = 17; Carb, n = 15 in 4 independent experiments done in triplicate) and RyR2KO cells (B;
*P = 0.0107, ****P < 0.0001; One-way ANOVA, Dunnett’s post-hoc test; (basal, n = 12; Gluc, n = 8; Carb, n = 14
in 3 independent experiments done in triplicate). Lines represent means ± SD. (c) Basal and stimulated IP1
accumulation was significantly reduced in RyR2KO INS-1 cells as compared to INS-1 cells (****P < 0.0001;
Two-way ANOVA, Šídák’s post-hoc test). Data re-plotted from (a and b) for comparison. (d) Representative
images of fixed, saponin permeabilized control INS-1 and RyR2KO cells stained with a primary antibody against
PIP2, followed by IgG-κ binding protein conjugated to CFL 488. Scale bars = 50 μm. The mean fluorescence
intensity was slightly greater in RyR2KO cells compared to control INS-1 cells. ****P < 0.0001 (unpaired t-test)
INS-1: n = 1294 cells; RyR2KO: n = 1377 cells from 3 independent experiments. Lines represent mean ± SD.
(e) Representative immunoblots of IRBIT in control INS-1 and RyR2KO cells (top) and quantitation of IRBIT
levels, normalized to actin, in control INS-1 cells and R
 yR2KO cells (n = 3). ***P < 0.0007 (unpaired t-test). Lines
represent mean ± SD.
were taken of fixed cells labeled with a primary AHCY antibody, and an Alexa Fluor 488-conjugated secondary
antibody, counterstained with Hoechst 33,342 to define the nuclei (Fig. 6a). Control experiments with primary
antibodies omitted resulted in cells with negligible Alex Fluor 488 fluorescence (Fig. 6b). In control INS-1 cells,
AHCY is preferentially localized in the nucleus relative to the cytoplasm (4:1 ratio) (Fig. 6a, c). In RyR2KO cells,
AHCY localized to the nucleus relative to the cytoplasm (4:1 ratio), but more AHCY was detected in the nucleus
compared to control INS-1 cells. Deletion of IRBIT resulted in a marked depletion of AHCY in the cytoplasm,
resulting in a nucleus to cytoplasm ratio of 13:1 (Fig. 6a, c). However, the total amount of AHCY detected in
the nucleus of IRBITKO cells was reduced compared to control INS-1 cells (Fig. 6c). Thus, deletion of RyR2 or
IRBIT correlates with either increased nuclear AHCY ( RyR2KO cells), or a sharp decrease in non-nuclear localized AHCY (IRBITKO cells). Increased accumulation of AHCY in the nucleus could potentially increase DNA
methyltransferase activity (Fig. 6d).

Regulation of INS1 and INS2 gene methylation by RyR2 and IRBIT. We examined the possibility that insulin genes in the knockout cells were differentially methylated. PCR amplification of genomic DNA
regions, with or without digestion by a methylation-dependent endonuclease using primers that flank potential
methylation sites (Fig. 7a, b), provides a measure of the relative amount of DNA methylation in the amplified
region26. Comparing PCR amplification at promoter regions upstream of the translation start site of the INS1
(Fig. 7c) and INS2 (Fig. 7d) genes revealed low methylation that was not different between RyR2KO, IRBITKO, or
control cells. The single CpG site in intron 1 of the INS1 gene (1-UP4) was extensively methylated but not altered
by deletion of RyR2 or IRBIT (Fig. 7c). Increased methylation was observed in the proximal portion of exon 2
of INS1 (Fig. 7c). At 1DS3, DNA methylation was increased in I RBITKO and R
 yR2KO cells compared to controls.
In the 1DS2 region, increased DNA methylation was only observed in the IRBITKO cells. DNA methylation in
the 1DS2 region is much higher (~ tenfold) compared to the 1-DS1 and 1-DS3 regions. A similar analysis of the
INS2 gene (Fig. 7d) showed high methylation at regions downstream of the translation start site compared to
upstream regions. An increase in DNA methylation was observed in Exon 2 of the INS2 gene of I RBITKO and
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Figure 4.  Characterization of IRBITKO cells (a) Genomic sequence within exon 6 of the rat AHCYL1 gene with
sequences from two clones derived from CRISPR-Cas9 gene editing of INS-1 cells. The underlined nucleotides
indicate the site of the indel induced by gene editing in each clone. Each indel induced a frameshift resulting
in the premature stop codon shown in red. (b) Immunoblot for IRBIT in control INS-1 cells, R
 yR2KO cells, and
IRBITKO cells. Blot shown is representative of 4 independent experiments. (c) RyR2 and IRBIT mRNA levels in
RyR2KO and IRBITKO cells relative to control INS-1 cells. Each point represents an independent experiment done
in triplicate. RyR2KO, n = 4, IRBITKO n = 3 (***P = 0.0008, **P = 0.0046, One-sample t-test). Glyceraldehyde-3phosphate dehydrogenase mRNA was used as the reference for the data shown. (d) Basal levels of cytoplasmic
Ca2+ as assessed with fura-2 AM (340/380 nm) in KRBH. INS-1: n = 67 cells; RyR2KO: n = 28 cells; IRBITKO:
n = 60 cells from 3 independent experiments. **P = 0.002; *P = 0.015 (one-way ANOVA with Tukey’s post-hoc
test). (e) Ca2+ release stimulated by 5 mM caffeine (AUC) in control INS-1, R
 yR2KO, and IRBITKO cells. IRBITKO:
n = 61 cells (3 independent experiments). Control and RyR2KO data are the same as presented in Fig. 1d.
****P < 0.0001; **P 0.0014 (one-way ANOVA with Tukey’s post-hoc test). (f) ER Ca2+ levels measured with
D1ER (ratio of YFP:CFP fluorescence intensity) before or after the addition of 1 µM thapsigargin. ****P < 0.0001;
*P = 0.019. INS-1: basal n = 217 cells, thaps n = 230 cells; RyR2KO: basal n = 229 cells, thaps n = 296 cells; IRBITKO:
basal n = 147 cells, thaps n = 272 cells from 3 independent experiments. (one-way ANOVA with Tukey’s post-hoc
test). There was no significant difference in ratios between thapsigargin-treated INS-1, R
 yR2KO, or IRBITKO cells
(one-way ANOVA). (g) Representative time courses of Ca2+ oscillations stimulated by 7.5 mM glucose from a
baseline of 0 mM glucose in I RBITKO cells in the presence or absence of 1 µM xestospongin C. (h) Xestospongin
C reduces the Ca2+ response (AUC) to 7.5 mM glucose in IRBITKO cells. **P = 0.0037; Glucose n = 16 cells,
Glucose + Xesto n = 14 cells from 3 independent experiments (unpaired t-test). (i) Comparison of C
 a2+ integral
(AUC) upon stimulation with 7.5 mM glucose in control INS-1, RyR2KO, and IRBITKO cells. ****P < 0.0001;
**P = 0.0024 (one-way ANOVA with Tukey’s post-hoc test). INS-1 n = 58 cells, RyR2KO n = 53 cells, IRBITKO n = 16
cells from 3 independent experiments, respectively. Data from INS-1 and R
 yR2KO cells shown in Fig. 2b and e,
were combined and replotted with data from IRBITKO cells for comparison. Lines represent mean ± SD.
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Figure 5.  RyR2/IRBIT regulate insulin secretion and content (a) Insulin secretion stimulated by 7.5 mM
glucose in INS-1, R
 yR2KO, and IRBITKO cells is inhibited by 2 µM nicardipine, but not 1 µM xestospongin
C. ****P < 0.0001; ***P = 0.0008; *P = 0.017 (n = 9 from 3 independent experiments). (two-way ANOVA
with Dunnett’s post-hoc test.) (b) Insulin secretion at both 2.5 mM and 7.5 mM glucose was reduced by
RyR2 deletion and IRBIT deletion. ####P < 0.0001 compared to 2.5 mM glucose; ****P < 0.0001; ***P < 0.001
compared to INS-1 (n = 9 from 3 independent experiments). (two-way ANOVA with Tukey’s post-hoc test).
(c) Insulin content, normalized to total cellular protein in INS-1, RyR2KO, and IRBITKO cells. ***P = 0.0004;
**P = 0.0076; *P = 0.0221 (n = 3) (one-way ANOVA with Tukey’s post-hoc test). (d) Phosphorylation of ERK1/2
in response to 2.5 mM or 7.5 mM glucose (Glc), 7.5 mM glucose + 50 nM GLP-1, or 7.5 mM glucose + 15 nM
EGF. Immunoblot shown is representative of 6 independent experiments. Quantitation-INS-1: **P = 0.0058;
****P < 0.0001 compared to 2.5 mM glucose; ###P = 0.0008 (GLP-1 + 7.5 mM Glc) and P = 0.0004 (EGF + 7.5 mM
Glc) compared to 7.5 mM glucose. RyR2KO: **P = 0.0048; ****P < 0.0001 compared to 2.5 mM glucose;
##
P = 0.0031 (GLP-1 + 7.5 mM Glc) and P = 0.0056 (EGF + 7.5 mM Glc) compared to 7.5 mM glucose. IRBITKO:
**P = 0.0012; ****P < 0.0001, **P = 0.0064 compared to 2.5 mM glucose; #P = 0.0383 (GLP-1 + 7.5 mM Glc)
compared to 7.5 mM glucose (one-way ANOVA with Tukey’s post-hoc test, n = 6 separate experiments for each
group). (e) mRNA levels of INS1 and INS2 transcript in RyR2KO and IRBITKO cells relative to control INS-1
cells, as assessed by rt-qPCR. RyR2KO: INS1, **P = 0.0042 (n = 4); INS2, **P = 0.0014 (n = 4). IRBITKO: INS2,
*P = 0.0164 (n = 3) (one-sample t-test). Glyceraldehyde-3-phosphate dehydrogenase mRNA was used as the
reference for the data shown. Equivalent results were obtained using phosphoglycerate kinase mRNA as the
reference (data not shown). Lines represent mean ± SD.
RyR2KO cells compared to controls, with ~ tenfold higher methylation in the 2-DS1 regions compared to the
2-DS2 region. Overall, deletion of RyR2 or IRBIT increased the methylation of CpG sites within exon 2 of both
INS1 and INS2, but not in the hypomethylated upstream/promoter regions.

Regulation of the INS‑1 cell proteome by RyR2 and IRBIT.

To assess the effect of RyR2 or IRBIT
deletion on the proteome of INS-1 cells, we performed LC–MS/MS analysis of INS-1, RyR2KO, and IRBITKO
cells. Downregulated proteins were considered as proteins with L
 og2(Fold-Change) < −1 and average MS/
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Figure 6.  RyR2/IRBIT regulate nuclear localization of AHCY (a) Images of indicated cells fixed and stained
with anti-AHCY antibodies and Alexa Fluor 488-conjugated secondary antibodies. Nuclei are stained with
Hoechst 33,342. (b) Images of indicated cells fixed and stained as in A, except that the primary antibodies were
omitted. Scale bars = 20 μm. (c) Quantification of Alexa Fluor 488 fluorescence intensity in nuclei vs outside
of nuclei in images of cells stained as in A. n = 195 (60 + 73 + 62) cells for INS-1 nucleus; n = 280 (58 + 85 + 137)
cells for RyR2KO nucleus; n = 355 (133 + 34 + 188) for IRBITKO nucleus; n = 50 (13 + 17 + 20) cells for INS-1
cytoplasm; n = 55 cells (14 + 20 + 21) for RyR2KO cytoplasm; n = 52 (13 + 19 + 20) cells for IRBITKO cytoplasm
from 3 independent experiments for each cell line. Inset numbers represent the nucleus:cytoplasm ratio of Alexa
Fluor 488 fluorescence intensity. ****P < 0.0001; ****P < 0.0001 compared to both INS-1 cyto and IRBIT cyto
(one-way ANOVA with Tukey’s post-hoc test). Lines represent mean ± SD. (d) Model for the regulation of DNA
methylation by loss of IRBIT.
MS count ratio < 0.5, compared to control. Similarly, upregulated proteins were considered as proteins with
Log2(Fold-Change) > 1 and average MS/MS count ratio > 2, compared to control.
Deletion of RyR2 resulted in the upregulation of 159 proteins (Fig. S1) and downregulation of 155 proteins
(Fig. S2). Deletion of IRBIT resulted in increased levels of 75 proteins (Fig. S3) and decreased levels of 62 proteins
(Fig. S4). Of these, 24 were more abundant in both R
 yR2KO and I RBITKO cells (Fig. 8a) and 17 were less abunKO
KO
dant in both RyR2 and IRBIT cells (Fig. 8b). Gene ontology analysis for overrepresentation of differentially
regulated proteins in specific cellular component, biological process, or molecular function categories (Figs.
S5 and S6), revealed that proteins more abundant in R
 yR2KO cells were overrepresented in cellular component
categories that clustered around synaptic proteins, nuclear proteins, and mitochondrial proteins. Overrepresentation of proteins with increased abundance in R
 yR2KO cells in biological process (gene expression, cellular
nitrogen compound biosynthetic processes, RNA metabolic processes, chromatin organization) and molecular
function (RNA binding, mRNA binding, nucleotide catalytic activity, RNA catalytic activity) categories suggest
that RyR2 activity may regulate transcription and translation and/or mRNA processing. Proteins more abundant
in IRBITKO cells were overrepresented in three cellular component categories related to mitochondria (mitochondrial matrix, mitochondrial protein-containing complexes, intracellular organelle lumen). Proteins with
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Figure 7.  RyR2/IRBIT regulate methylation of the INS1 and INS2 genes (a) Schematic of the INS1 and INS2
genes with positions of listed primer pairs. (b) Number of potential methylation sites (CpG) within the sequence
amplified by each primer set. (c) DNA methylation in listed regions of the INS1 gene in INS-1, I RBITKO, and
RyR2KO cells were measured by methylation-dependent qPCR (MD-qPCR). The relative fold changes shown
are differences in ΔCq values of the target region normalized to the 1-UP1 region, which stays unmethylated
between all cell types. ΔCq is the change in the Cq values for FspEI digested DNA relative to Cq values of the
respective undigested DNA. ****P < 0.0001 (two-way ANOVA with Dunnett’s post-hoc test). Data shown are
the means ± SD for 3 independent experiments. (d) DNA methylation in indicated regions of the INS2 gene in
INS-1, IRBITKO, and RyR2KO cells was measured by methylation-dependent qPCR (MD-qPCR) as described in
C. ****P < 0.0001; ***P < 0.001 (two-way ANOVA with Dunnett’s post-hoc test). Data shown are the means ± SD
for 3 independent experiments.

Figure 8.  Deletion of RyR2 or IRBIT in INS-1 cells differentially regulates an overlapping set of proteins (a)
Venn diagram illustrating the overlap of proteins with increased abundance in R
 yR2KO and IRBITKO cells.
(b) Venn diagram illustrating the overlap of proteins with decreased abundance in R
 yR2KO and IRBITKO
cells. Overlapping proteins are listed in the boxes below each diagram, along with other proteins of interest
differentially regulated in either RyR2KO cells or IRBITKO cells. Proteins with decreased abundance were defined
as Log2(Fold-Change) < -1 and average MS/MS count ratio < 0.5, compared to control. Similarly, proteins with
increased abundance were defined as proteins with L
 og2(Fold-Change) > 1 and average MS/MS count ratio > 2,
compared to control. For complete list of differentially regulated proteins see Supplementary Figs. 1–4.
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decreased abundance in R
 yR2KO cells are mainly overrepresented in categories related to organelle structure
and function. Small GTPase binding proteins were overrepresented among proteins with both increased and
increased abundance in RyR2KO cells. The smaller group of proteins with decreased abundance in IRBITKO cells
showed modest overrepresentation (< twofold) in two cellular component categories, intracellular anatomical
structure and cytoplasm.

Discussion

Deletion of RyR2 resulted in no detectable band upon western blot with a pan RyR antibody and essentially
abolished mobilization of ER C
 a2+ by caffeine (Fig. 1), suggesting that RyR2 is the predominant, if not sole, functional RyR in INS-1 cells. This result is consistent with studies showing that RyR2 is the prominent RyR transcript
detected in INS-1 cells5 and human i slets9. RyR2 also contributes to resting cytoplasmic [Ca2+] (Fig. 1F) and PLC
activity (Fig. 3). Our results suggest a complicated interplay between RyR2 and I P3 receptors. In control cells,
xesto had no effect on the Ca2+ integral in response to glucose, but did shorten the period between Ca2+ oscillations. In contrast, deletion of RyR2 led to a significant increase in the C
 a2+ integral in response to glucose, and
xesto both decreased the Ca2+ AUC and increased the period between oscillations in RyR2KO cells upon glucose
stimulation. This suggests the decrease in IRBIT detected in RyR2KO cells is functionally significant, leading to
enhanced IP3R activation during glucose stimulation. RyR2 deletion markedly reduced both basal and stimulated
IP1 accumulation compared to control INS-1 cells, suggesting that RyR2 plays an important role in supporting
PLC activity in INS-1 cells. Store-operated Ca2+ entry (SOCE) plays a key role in supporting PLC activity in
pancreatic β-cells27, and RyR2 is implicated in gating SOCE channels in rat vascular smooth m
 uscle28. It will be of
interest to determine if a similar mechanism can account for the decreased PLC activity observed in RyR2KO cells.
In addition to IP3R, IRBIT also regulates many other p
 roteins29. Thus, phenotypes of R
 yR2KO cells may be
attributed to either loss of RyR2 C
 a2+ release directly, or to downregulation of IRBIT. Caffeine-stimulated C
 a2+
KO
transients were maintained in I RBIT cells, indicating that RyR2 function is retained in the absence of IRBIT.
However, the response was significantly reduced compared to control INS-1 cells. This is likely the result of a
reduced pool of C
 a2+ available for release via RyR2, as the ER C
 a2+ levels in I RBITKO cells were reduced compared
to control and R
 yR2KO cells. As expected, deletion of IRBIT led to an increase in the C
 a2+ response to glucose
compared to controls cells, the result of enhanced activation of I P3 receptors during glucose stimulation, as in
RyR2KO cells. It’s not clear why IRBIT levels/activity are reduced upon RyR2 deletion. We speculate that RyR2
may play a critical role in the phosphorylation of IRBIT on Ser 68 by a C
 a2+-dependent kinase, leading to further
phosphorylation that’s required for IP3 receptor binding18. Further, unphosphorylated IRBIT is susceptible to
proteolytic cleavage30. Thus, hypo-phosphorylation of IRBIT could account for both the elevated activity of I P3
receptors, and the reduced IRBIT levels observed in R
 yR2KO cells.
Deletion of either RyR2 or IRBIT had marked effects on insulin secretion, cellular insulin content, and insulin
gene transcript levels. RyR2 deletion had the greatest effect on basal (2.5 mM) and glucose stimulated insulin
secretion, but IRBIT deletion also reduced basal and glucose-stimulated insulin secretion compared to control
INS-1 cells. Although elevated Ca2+ release from IP3 receptors during glucose stimulation was a hallmark of both
RyR2 and IRBIT deletion, xesto didn’t inhibit insulin secretion in either control, R
 yR2KO, or I RBITKO cells. Our
results show that even when IP3 receptors are highly active, they don’t contribute to glucose-stimulated insulin
secretion in INS-1 cells. This is consistent with previous reports that IP3 receptors are upregulated in the β-cells of
type 2 diabetics, but associated with impairment of glucose-stimulated insulin secretion and β-cell d
 ysfunction31.
To understand what might account for this reduction in insulin secretion, we examined the insulin content
of control INS-1, RyR2KO, and I RBITKO cells and found an ~ 70% decrease in insulin content of RyR2KO cells, and
an ~ 40% decrease in insulin content in I RBITKO cells compared to controls. This decrease in insulin content was
accompanied by a similar decrease in INS2 gene transcript levels in both RyR2KO and IRBITKO cells. Interestingly, the level of INS1 transcript detected in RyR2KO cells was reduced compared to controls, but wasn’t different
in IRBITKO cells. Although the role of IRBIT as a regulator of IP3 receptor activation is well studied, it’s clear
that IRBIT plays many other roles32. IRBIT contains a highly conserved, but catalytically inactive, S-adenosyl
homocysteine hydrolase (AHCY) d
 omain33. By virtue of this domain, IRBIT can bind to and may regulate the
activity of catalytically active AHCY24 as well as its distribution between the cytoplasm and the nucleus25. Since
AHCY degrades S-adenosyl homocysteine (SAH), a potent inhibitor of DNA m
 ethyltransferases34, dysregulation
of AHCY by loss of IRBIT could play a role in the increased INS1 and INS2 gene methylation that we observed
in RyR2KO and I RBITKO cells. While deletion of RyR2 slightly increased nuclear AHCY localization, deletion of
IRBIT caused a marked shift of AHCY from the cytoplasm into the nucleus, though the total amount of AHCY
immunostaining detected in the nuclei of IRBITKO cells was reduced compared to controls. Increased AHCY
activity in the nucleus could disinhibit DNA, RNA, and protein methyltransferases (Fig. 6d). AHCY binds to
chromatin near transcription start sites of active g enes35, suggesting that AHCY regulation of DNA methylation
may be spatially specific. Given that AHCY is only active as a homotetramer36, incorporation of IRBIT via its
AHCY domain into AHCY complexes could diminish AHCY activity. We speculate that, in addition to controlling AHCY nuclear accumulation, IRBIT may also limit AHCY activity. Such a scenario would imply that AHCY
in the absence of IRBIT not only accumulates preferentially in the nucleus, but may be catalytically more active.
The shift of AHCY from the cytoplasm to the nucleus in I RBITKO cells and the corresponding changes in insulin mRNA levels were coincident with an increase in methylation of both the INS1 and INS2 genes downstream
of the translation start site in intron 2. The promoter/upstream regions were hypomethylated in both INS1 and
INS2, which didn’t change upon deletion of either RyR2 or IRBIT, consistent with the finding that hypomethylation of the promoter regions of insulin genes serves as a marker of islet cell i dentity37. Methylation of genes
within the first exon (or within ~ 200 bp downstream of the transcription start site) is highly correlated with
inhibition of t ranscription38. The role of increased methylation in INS1 and INS2 genes in RyR2KO and IRBITKO
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cells in exon 2 is unclear. Studies in pancreatic islets from NOD mice found an inflammation-mediated increase
in INS1 exon 2 and INS2 exon 1 methylation and a corresponding decrease in INS1 and INS2 mRNA39. The
same study found no correlation between methylation of the INS2 promoter region and INS2 mRNA levels. The
human insulin gene is hypermethylated at the TSS + 63 position, corresponding to the rat INS2 2-UP2 region,
in type 2 diabetic patients, and this hypermethylation is correlated with decreased INS mRNA40. However, we
observed extremely low methylation in this region in both R
 yR2KO, IRBITKO, and control cells. While it’s possible
KO
increased methylation in exon 2 of INS2 in RyR2 and IRBITKO cells contributes to the decreased INS2 mRNA
levels, that conclusion is not currently supported.
The differential effect of RyR2 or IRBIT deletion on INS1 mRNA levels was also coincident with differential
changes in methylation of the INS1 gene in exon 2. While CpG site(s) in exon 2 (1-DS3) are hypermethylated in
both RyR2KO and I RBITKO cells, a specific CpG site in exon 2 (ATG + 136) in the INS1 gene is hypermethylated
in IRBITKO cells compared to control and RyR2KO cells. It is currently unclear whether increased methylation
within the 1-DS3 region accounts for the decrease in INS1 mRNA in R
 yR2KO cells, or if the specific increase in
methylation at + 136 is responsible for the maintenance of INS1 mRNA levels in IRBITKO cells. However, this
differential regulation of INS1 mRNA levels may account for the smaller decrease in insulin content in IRBITKO
cells, compared to RyR2KO cells. It will be of interest to determine if RyR2 or IRBIT deletion results in a more
global increase in DNA methylation.
Exploratory proteomics analysis suggests that deletion of RyR2 or IRBIT differentially regulates a partially
overlapping set of proteins. It’s not clear if this regulation is occurring pre- or post-translationally, but the
reduction of IRBIT protein in R
 yR2KO cells, with no decrease in mRNA levels, demonstrates that RyR2 activity
is capable of regulating protein levels post-transcriptionally. GO analysis revealed that RNA binding/processing
proteins are overrepresented in the population of proteins increased in abundance by RyR2 deletion, suggesting
altered RNA processing in the absence of RyR2. Mitochondrial proteins are also overrepresented in the population of proteins increased in abundance by RyR2 or IRBIT deletion, perhaps reflecting the proposed role of IRBIT
in regulating Ca2+ flux between the ER and mitochondria41. The decrease in ATG5 protein in both R
 yR2KO and
IRBITKO cells might also explain the increased levels of some mitochondrial proteins, since deletion of ATG5
(autophagy-related gene 5) in T-lymphocytes differentially regulates mitochondrial protein levels and mitochondrial mass42. GTPase binding proteins are overrepresented in populations of both increased and decreased
abundance proteins in R
 yR2KO cells, suggesting a switch in the complement of modulators of small GTPase
proteins, which play critical roles in vesicle trafficking43. Finally, proteins more abundant upon RyR2 deletion
are overrepresented in several categories related to the nucleus, including four components of transcription
repressor complexes- Rcor1 (REST co-repressor 1), Ncor1 (nuclear receptor corepressor 1), Ctbp2 (c-terminal
binding protein 2), and Coro2a (coronin 2a). Rcor1, also increased in abundance in I RBITKO cells, and Ctbp2 are
of particular interest since they are part of the RE-1 Silencing Transcription factor (REST) repressor complex44,
which represses genes critical for β-cell function, but is inactivated during differentiation. Several proteins
repressed by REST (Pcsk1, neuroendocrine convertase 1; Chga, chromogranin A; Chgb, secretogranin; Stmn2,
stathmin 2)44 are reduced in abundance in R
 yR2KO cells. Thus loss of RyR2 function may permit expression of
some components of the REST repressor complex, and repression of a subset of genes critical for β-cell function.
Some of the differentially regulated proteins identified in R
 yR2KO and IRBITKO cells are dysregulated in
diabetes and/or play a key role in β-cell function. Among these are PCSK145 and ORMDL1/2 (sphingolipid
biosynthesis regulator 1/2)46 which are reduced in both RyR2KO and IRBITKO cells, Abat (GABA aminotransferase)47, and Kcnj11 (Kir6.2)48 which are reduced in RyR2KO cells. The Ca2+-dependent adhesion molecule Cdh2
(N-cadhedrin) is also reduced in both RyR2KO and IRBITKO cells. Cell adhesion and spreading via N-cadhedrin
enhances GSIS49. The pancreas-specific deletion of HUWE1 (HECT, UBA, and WWE domain containing E3
ubiquitin ligase 1), which is reduced in both R
 yR2KO and IRBITKO cell, leads to increased β-cell apoptosis and
reduced β-cell mass50. Anks4b which is, together with its binding partner Ush1c (Harmonin), more abundant
in both R
 yR2KO and I RBITKO cells, increases susceptibility to ER stress-induced apoptosis when overexpressed
in MIN6 cells51. Finally, some key proteins in β-cell function were specifically reduced in IRBITKO cells, including mTOR (mammalian target of rapamycin)52, Creb1 (cAMP response element-binding protein 1)53, and IRS2
(insulin receptor substrate 2)54.
In summary, deletion of RyR2 or IRBIT both enhanced IP3 receptor activation during glucose stimulation, and
reduced insulin secretion, content, and INS2 mRNA. In addition, the INS1 and INS2 genes were hypermethylated
in exon 2 upon RyR2 or IRBIT deletion, coincident with alterations in the nuclear localization of AHCY. One
limitation of this study is that, while insulin content is clearly reduced by RyR2 or IRBIT deletion, it’s not clear if
this reduction accounts for the reduced secretion, or if granule trafficking/exocytosis is also impaired by RyR2
or IRBIT deletion. Furthermore, the relationship between RyR2 activity and IRBIT levels remains unknown.
Nevertheless, IRBIT regulation of AHCY localization and, potentially, activity positions it to regulate the activity
of protein, RNA, and DNA methyltransferases via modulation of local SAH levels, and regulate the proteome. It
will be of interest to determine if pathophysiological perturbation of RyR2 activity or dysregulation of ER C
 a2+
levels in pancreatic β-cells leads to dysregulation of IRBIT activity.

Materials and methods

Chemicals and reagents. Antibodies to RyR (pan-specific), AHCY, AHCYL1, and β-actin, and mouse
IgG-κ binding protein conjugated to CFL 488 were from Santa Cruz Biotechnology (Dallas, TX). Goat antimouse IgG conjugated to IRDye 680RD and goat anti-rabbit IRDye 800CW were from LI-COR (Lincoln, NE).
Antibodies to phosphatidylinositol 4,5 bisphosphate (PIP2) were from Echelon Biosciences (Salt Lake City, UT).
Goat anti-mouse IgG conjugated to horseradish peroxidase was from BioRad (Hercules, CA). ERK1/2 and
pERK1/2 antibodies were from Cell Signaling Technology (Danvers, MA). Oligonucleotides encoding gRNA
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and primers were obtained from Integrated DNA Technologies (Coralville, IA). The pSpCas9(BB)-2A-Puro
(PX459) V2.0 vector was a gift from Feng Zhang (Addgene plasmid # 62988). T4 polynucleotide kinase and
T7 DNA ligase were from New England Biolabs (Ipswich, MA). Fast AP thermosensitive alkaline phosphatase
and FastDigest Bpil were from Thermo Scientific (Waltham, MA). Plasmid-Safe ATP-Dependent DNase was
from Lucigen (Middleton, WI). Surveyor Mutation Detection Kit S100 was from Integrated DNA Technologies
(Coralville, IA).
Chemicals- Fura-2 AM was from Invitrogen (Carlsbad, CA). Xestospongin C was from Cayman Chemical
(Ann Arbor, MI). All other reagents, unless otherwise indicated, were from Sigma-Aldrich (St. Louis, MO).

Cell culture. INS-1 cells (Gift of Dr. Ming Li, Tulane University) were cultured in RPMI-1640 medium
(Sigma-Aldrich) supplemented with 10% fetal bovine serum (Qualified,Gibco), 11 mg/mL sodium pyruvate,
10 mM HEPES, 100 U/mL penicillin, 100 μg/mL streptomycin, and 50 μM mercaptoethanol at 37 °C, 5% C
 O 2.
Construction of Cas9 plasmids. gRNA sequences were designed using the crispr.mit.org website. Oligonucleotides were synthesized by IDT (Coralville, IA).
RyR2 gRNA (Exon 6): 89-Forward 5’-CACCGTT TGTCGGTGGAAGACCGGG-3’.
89-Reverse: 5’-AAACCCCGGTCTTCCACCGACAAA-3’.
92-Forward: 5’-CACCGCCGGTCTTCCACCGACAAAC-3’.
92-Reverse: 5’-AAACGTT TGTCGGTGGAAGACCGG-3’.
RyR2 Exon 6 primers: Forward 5’-GTGGAAATCAGTGCGGAGTC-3’.
Reverse: 5’-TGTATTTGGGTTCTGCAAAGG-3’.
AHCYL1 gRNA (Exon 6): 75-Forward 5’-CACCGCATTGACCGCTGTGTCAACA-3’.
75-Reverse 5’-AAACTGT TGACACAGCGGTCAATG-3’.
AHCYL1 Exon 6 primers: Forward 5’-GAGGCATCTGTTGCTGTTCA-3’.
Reverse 5’-CTCCAGCATTCCTGCT TCAG-3’.
gRNA oligonucleotides were subcloned into pSpCas9(BB) using BbsI (New England Biolabs). Ligation products were used to transform competent DH5α E. coli, and transformants were selected on Luria broth-agar plates
containing 100 µg/mL ampicillin. Plasmid DNA was purified and sequenced (Purdue Genomics Core Facility)
to confirm assembly of the desired construct.
Generation and validation of knockout clones. INS-1 cells were transfected with 2 μg RyR2- or IRBITtargeted gRNA/Cas9 plasmid or pEGFP-N1 (selection control) using Lipofectamine 2000 (Invitrogen) per
manufacturer’s instructions. 72 h post-transfection, cells were selected with 3 μg/mL puromycin until no cells
remained in the pEGFP-N1 transfected well. Individual clones from the gRNA/Cas9 transfected cells were then
isolated by limiting dilution in 96-well plates (Corning). RPMI-1640 media was changed weekly for 4 weeks,
and clones were gradually expanded. Once expanded, clones were plated at 90% confluency in 96-well plates
and allowed to incubate overnight at 37 °C, 5% CO2. Cells were lysed and genomic DNA was extracted using
QuickExtract DNA Extraction Buffer (Lucigen) per the manufacturer’s instructions. Extracted genomic DNA
from INS-1, RyR2KO, or IRBITKO cells was subjected to PCR amplification (Herculase II Fusion DNA Polymerase
and 5X Herculase II PCR Buffer and dNTP (Agilent Techologies) using primers flanking the region targeted by
the gRNA. Purified amplicons were sequenced at the Purdue University Genomics Core.
Single‑cell intracellular Ca2+ assays. INS-1 and RyR2KO cells were either plated in a 35 mm tissue culture dish (Corning) containing a poly-D-lysine coated round glass coverslip (for assays using perfusion; Warner
Instrument) or plated in a poly-D-lysine coated 4-chambered 35 mm glass bottom tissue culture dish (for assays
not using perfusion; Cellvis). Cells were incubated overnight in RPMI-1640 media at 37 °C, 5% C
 O2. For glucose
stimulation assays, cells were deprived of glucose for an additional 24 h in low glucose RPMI-1640 media. Cells
were washed twice with PBS prior to loading with 3 μM of the Ca2+ indicator Fura-2 AM (Invitrogen) diluted
in a modified Krebs–Ringer buffer [KRBH: 134 mM NaCl, 3.5 mM KCl, 1.2 mM K
 H2PO4, 0.5 mM M
 gSO4,
1.5 mM CaCl2, 5 mM NaHCO3, 10 mM HEPES (pH 7.4)] supplemented with 0.05% fatty acid free BSA at room
temperature for 1 h. The KRBH containing Fura-2 AM was then removed, and the cells were washed twice with
KRBH, then equilibrated for 30 min at room temperature in KRBH alone or KRBH containing a 2 × concentration of indicated inhibitors. For perfusion assays, the glass coverslip was mounted on a perfusion chamber
attached to the stage of an Olympus IX50 inverted microscope equipped with a PlanApo 40 × objective lens (0.95
na) and solutions/stimuli were perfused to the chamber at a constant flow rate (1 mL/min) at room temperature.
For assays not using perfusion, the 4-chambered 35 mm dish was mounted on a chamber attached to the stage
of the microscope. Cells were stimulated with the indicated stimulus at a 2 × concentration. Cells were alternatively excited at 340/11 nm and 380/20 nm wavelengths using a band pass filter shutter (Sutter Instrument) and
changes in intracellular C
 a2+ were measured by recording the ratio of fluorescence intensities at 508/20 nm in
time lapse (time interval of 0.6 s) using a Clara CCD camera (Andor Technology). Background subtraction from
the raw 340/11 nm and 380/20 nm wavelengths was performed, then isolated single cells were selected as regions
of interest (ROI) and the 340/11 nm/380/20 nm ratios for each ROI were measured using MetaMorph image
analysis software (Molecular Devices). All single-cell C
 a2+ transients were normalized to their baseline intracellular Ca2+ level, which was obtained by averaging the 340/11 nm/380/20 nm ratios during the first minute of
each experiment when no stimulus was present. C
 a2+ transients are plotted as normalized 340/11 nm/380/20 nm
ratios against time.
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Intracellular Ca2+ measurements in 96‑well plates.

INS-1 and R
 yR2KO cells were plated at 70–90%
confluency in black-walled 96-well plates (Corning) in RPMI-1640 media and incubated overnight at 37 °C,
5% CO2. Cells were washed twice with PBS and incubated with 100 μL 5 μM Fura-2 AM in KRBH for 1 h at
room temperature. The KRBH containing Fura-2 AM was removed, the cells were washed twice with KRBH,
and equilibrated for 30 min in 100 μL KRBH at room temperature. Cells were stimulated by injection of 100 μL
10 mM caffeine (2x) or KRBH (buffer control). Changes in intracellular Ca2+ concentrations were measured by
recording the ratio of fluorescence intensities at 508/20 nm resulting from excitation of Fura-2 AM at 340/11 nm
or 380/20 nm (center/bandpass) using a Synergy 4 multimode microplate reader (BioTek). Ratios were acquired
every 0.7 s for 15 s before injection and 2 min after injection. Data were corrected for injection artifact by subtracting the change in fluorescence ratio measured in cells injected with KRBH alone.

IP1 HTRF assays.

INS-1 and R
 yR2KO cells were plated at approximately 200,000 cells/well in an opaque
96-well tissue culture plate (Corning) and incubated overnight in low glucose RPMI-1640 media at 37 °C, 5%
CO2. Cells were washed with PBS and incubated in a pre-stimulation buffer [10 mM HEPES, 1 mM C
 aCl2,
0.5 mM MgCl2, 4.2 mM KCl, 146 mM NaCl (pH 7.4)] for 1 h at 37 °C, 5% CO2. The pre-stimulation buffer was
decanted, and stimulants and/or inhibitors at the concentrations indicated, were applied in the same buffer
supplemented with 50 mM LiCl to inhibit inositol monophosphate degradation were added to the cells and
incubated for 1 h at 37 °C, 5% C
 O2. Accumulation of IP1 was measured using the IP-One Gq Homogenous
Time-Resolved Fluorescence (HTRF) kit from Cisbio per the manufacturer’s instructions. The I P1 concentration
of each sample was interpolated by comparison to a standard curve of IP1 concentrations.

Endoplasmic reticulum Ca2+ measurements. INS-1 and RyR2KO cells were plated in a 6-well dish
(Corning) in RPMI-1640 media at 70–90% confluency and transfected with 1 μg DNA encoding the endoplasmic reticulum C
 a2+ indicator pcDNA-D1ER22 using Lipofectamine 2000 per the manufacturer’s instructions. 24 h after transfection, cells were transferred to a 4-chambered 35 mm glass bottom dish (Cellvis) coated
with poly-D-lysine. 16–24 h prior to imaging, cells were incubated in low glucose RPMI-1640 media overnight
at 37 °C, 5% C
 O2. D1ER FRET measurements were performed on a Nikon A1 confocal microscope using a
20 × objective. The CFP-YFP FRET pair was excited with a 457 nm argon laser line, and CFP and YFP (FRET)
emissions were collected using 482/35 nm and 525/25 nm PMT filters, respectively, before and after treatment
of cells with 1 µM thapsigargin for 30 min.
Insulin assays. INS-1 and RyR2KO cells were plated at 70–90% confluency in 24-well plates (Corning) in

RPMI-1640 media and incubated overnight at 37 °C, 5% C
 O2. 16–24 h prior to assay, cells were incubated in
serum-free, low glucose RPMI-1640 media supplemented with 0.1% fatty acid-free BSA overnight at 37 °C, 5%
CO2. Cells were washed once with PBS and pre-incubated with 1 mL fatty acid-free KRBH alone or containing
the working concentration of inhibitors for 30 min at 37 °C, 5% C
 O2. After 30 min, KRBH was removed and
replaced with either 1 mL KRBH or KRBH containing the indicated concentrations of stimulants, and cells were
stimulated for 30 min at 37 °C, 5% CO2. Supernatants were collected and stored at -20 °C until assayed. Cells
were lysed in 200 μL ice-cold RIPA lysis buffer supplemented with protease inhibitors (1 mM 4-(2-aminoethyl)
benzenesulfonyl fluoride hydrochloride, 800 nM aprotinin, 50 μM bestatin, 15 μM E-64, 20 μM leupeptin, and
10 μM pepstatin A) and lysates were transferred to 1.5 mL tubes on ice. After 20 min, lysates were clarified by
centrifugation (14,000 rcf for 10 min at 4 °C) and supernatants were transferred to new tubes. Protein content
was measured using the Pierce BCA Protein Assay Kit (Thermo Fisher) per the manufacturer’s instructions.
Insulin measurements were performed either using High-Range insulin ELISA (Alpco) or Insulin High-Range
assay kits (Cisbio). For insulin content assays, cells were extracted with 70% ethanol/0.18 M HCL for 12 h at
4 °C, then neutralized with 1 M Tris pH 8.0, (20-fold final dilution) before insulin and protein were assayed as
described above.

Immunoblotting. INS-1, RYR2KO, or IRBITKO cells were plated at 70–90% confluency in 6-well plates
(Corning) in RPMI-1640 media and incubated overnight at 37 °C, 5% C
 O2. The following day, cells were washed
once with ice-cold PBS and lysed in 200 μL TBS containing 1% Triton-X100 supplemented with protease inhibitors. Cells lysates were incubated on ice for 30 min and then transferred to 1.5 mL tubes to be clarified by
centrifugation (14,000 rcf for 10 min at 4 °C). Protein concentrations were determined using the BCA Protein
Assay kit (Thermo Fisher). 30 μg of each lysate was separated by SDS-PAGE on 8% acrylamide gels at 150 V for
1 h. Proteins were transferred onto PVDF membranes in ice-cold Towbin Buffer (25 mM Tris (pH 8.3), 192 mM
glycine,10% ethanol) at 100 V for 1 h. Membranes were blocked in 5% non-fat milk in TBS with 0.1% Tween
20 (TBST) for 1 h at room temperature. Blocked membranes were incubated with primary antibody (1:1000) in
5% milk in TBST overnight at 4 °C. The following day, membranes were washed 3 times with TBST and were
then incubated with secondary antibodies (IRDye 680RD goat anti-mouse IgG (1:10,000) or goat anti-mouse
IgG HRP (1:10,000)) in 5% milk in TBST for 1 h at room temperature. Blots were imaged on a LI-COR Odyssey
CLx imager and analyzed using Image Studio (IRDye 680RD) or an Azure Biosystems Sapphire imager (chemiluminescence). For RYR blots, crude microsomes were isolated using the Endoplasmic Reticulum Isolation Kit
(Sigma) per the manufacturer’s instructions. 4–6 confluent 15 cm dishes worth of cells were harvested by trypsin
for each cell line prior to microsome collection. All buffers were supplemented with protease inhibitors immediately prior to use. Crude microsomal pellets were resuspended in isotonic buffer (10 mM HEPES, pH 7.8,
with 0.25 M sucrose,1 mM EGTA, and 25 mM potassium chloride) supplemented with protease inhibitors and
homogenized by repeatedly passing through a 23 g needle. Protein concentrations were determined by Bradford
Assay (Thermo). Prior to electrophoresis, microsomes were heated to 65 °C for 10 min in Laemmeli sample
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buffer supplemented with 5% mercaptoethanol. 90–180 ug either INS-1 or RYR2KO microsomes were separated
by SDS-PAGE on 5% acrylamide gels at 75 V for 3 h. Proteins were transferred onto PVDF membranes in icecold Towbin Buffer, 10% methanol at 25 V for 16 h at 4 °C. Membranes were blocked in 3% BSA in TBST for
1 h at room temperature and then incubated with anti-RyR (F-1) (1:1000) in 3% BSA in TBST overnight at 4 °C.
Primary antibody was removed the following day, and membranes were incubated in goat anti-mouse IgG HRP
(1:10,000)) in 5% milk in TBST for 1 h at room temperature. Chemiluminescence was detected using standard
ECL reagents and imaged on Azure Biosystems Sapphire imager.

RT‑qPCR assays. Total RNA was extracted from the indicated cell lines using TRIzol (Thermo Fisher). 1 μg

of total RNA was used to transcribe cDNA using a high-capacity RNA-to-cDNA kit (Applied Biosystems) per
the manufacturer’s protocol. 10 ng of each cDNA was used to perform RT-qPCR using the PowerTrack SYBR
Green Master Mix (Thermo Fisher) in a Viia7 real-time PCR system (Applied Biosystems). The protocol for
RT-qPCR was as follows: initial activation at 95 °C for 5 min was followed by 45 cycles of denaturation at 95 °C
for 10 s, primer annealing at 62 °C for 30 s, and extension at 72 °C for 30 s, followed by a melting curve step.
Cycle threshold (Ct) values were determined for each primer pair, and ΔCT values were separately determined
for target mRNAs against two different reference genes, glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
and phosphoglycerate kinase 1 (PGK1). ΔΔCT values were calculated for each target mRNA in R
 yR2KO and
KO
-ΔΔCT
IRBIT cell lines relative to control INS-1 cells and were used to determine fold difference ( 2
). The oligonucleotides used in rt-qPCR experiments were designed using Primer-Blast online tool (https://www.ncbi.nlm.
nih.gov/tools/primer-blast/).
GAPDH-Forward: 5’ CAGGGCTGCCTTCTCT TGTG 3’.
Reverse: 5’ GATGGTGATGGGT TTCCCGT 3’.
PGK1 Forward: 5’ GCTCGTCTTTACTGCATCGG 3’.
Reverse: 5’ CCAGAGGCTACATACAGCGAA 3’.
INS1 Forward: 5’ CCTT TGTGGTCCTCACCTGG 3’.
Reverse: 5’ TGCCAAGGTCTGAAGATCCC 3’.
INS2 Forward 5’ GCAGGTGACCTTCAGACCT T 3’.
Reverse 5’ CAGAGGGGTGGACAGGGTAG 3’.
IRBIT Forward 5’ GCTACAACACAGGCTT TGGC 3’.
Reverse 5’ GGTTCGTGTGGACTGGTCAT 3’.
RyR2 Forward 5’ AGGACCTGACTGT TCTCCCC 3’.
Reverse 5’ TCCGTGGGTGGTATGGTAGA 3’.

DNA methylation‑dependent qPCR assay (MD‑qPCR). Genomic DNA was isolated from cells using
standard phenol: chloroform isolation protocol, followed by ethanol precipitation. The DNA was RNase treated
and purified again. 14 μg of sample DNA were digested overnight at 25 °C with CviQI restriction enzyme (NEB,
R0639L), which cuts outside the region of interest. The next day, the samples were purified, and 5 μg were digested
overnight at 37 °C with FspEI (NEB, R0662S), which recognizes CMC sites and creates a double-stranded DNA
break on the 3´ side of the modified cytosine at N12/N16. The purified CviQI and CviQI + FspEI digested DNA
were quantified by PicoGreen according to the manufacturer’s protocol (Life Technologies, P11495) using a
NanoDrop 3300 fluorescence spectrophotometer. The digested DNA was checked on an agarose gel to check the
digestion of the samples. The quantitative PCR was performed using 6 ng of singly cut (CviQI only) and doubly
cut (CviQI + FspEI) DNA for each sample, using the qPCR master mix EvaGreen according to the manufacturer’s conditions (MidSci, BEQPCR-S). The change in DNA methylation is represented by the relative fold change
in the Cq value as follows: 2^(ΔCq(S) − ΔCq(C)), where ΔCq is the Cq change in (CviQ1 + FspEI)—(CviQ1)
digested sample. C is the normalization control region, 1-UP1, which does not methylate, and S is the target
region to check the methylation. Standard deviations represent three technical and two biological replicates.
An increase in Cq value indicates a gain of DNA methylation. The primers were designed for INS1 and INS2
promoter region and their integrity was validated by assessing the size of PCR products on a polyacrylamide gel.
The oligonucleotides used in the MD-qPCR experiments were:
INS1 UP1 Forward 5’ GACGTCCAATGAGCGCTTTC 3’.
Reverse 5’ TTAAGGGCTCTAGGAGGGGT 3’.
INS1 UP2 Forward 5’ AACTGCT TCATCAGGCCATCT 3’.
Reverse 5’ AGGGGTAGGTAGGCAGATGG 3’.
INS1 UP3 Forward 5’ CTCCTAGAGCCCT TAATGG 3”.
INS1 UP3 Reverse 5’ GAGT TACTGGGTCTCCACTAGC 3”.
INS1 UP4 Forward 5’ AGGTATGTACTCTCCTGG 3’.
INS1 UP4 Reverse 5’ CCATGTAAGAGAGGAACC 3’.
INS1 DS1 Forward 5’ CTGTGGATGCGCT TCCTGC 3’.
Reverse 5’ CTCCACCAGGTGAGGACCAC 3’.
INS1 DS2 Forward 5’ GTGTGGGGAACGTGGT TTC 3’.
INS1 DS3 Forward 5’ CAAGTCCCGTCGTGAAGTG 3’.
INS1 DS2/3 Reverse 5’ GTGCCAAGGTCTGAAGATC 3’.
INS2 UP1 Forward 5’ GCTGACCTTCAGGTGCAAATC 3’.
Reverse 5’ TCCACAAACCCATAGCCCAC 3’.
INS2 UP2 Forward 5’ CCAGCTACAGTCGGAAACCA 3’.
Reverse 5’ CCACAGCGTCCCTCAAATCC 3’.
INS2 DS1 Forward 5’ CTGTGGATCCGCT TCCTGC 3’.
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Reverse 5’ GAAGAATCCACGCTCCCCAC 3’.
INS2 DS2 Forward 5’ GGAT TCT TCTACACACCCATG 3’.
Reverse 5’ CTCCACACCTAGGGCACAA 3’.

Immunocytochemistry.

Cells were plated at 50% confluency in poly-D-lysine coated 4-chamber glass bottom dishes (Cellvis) 16–24 h prior to fixation. The following day cells were washed once with PBS, then fixed in
4% paraformaldehyde in PBS for 10 min at room temperature (RT). Cells were then washed three times with PBS
and permeabilized in 0.2% Triton X-100 in PBS for 10 min at RT. Cells were blocked in 3% BSA in PBS for 1 h
at RT then incubated in primary antibody (mouse anti-AHCY 1:200 or mouse anti-PIP2 1:50) overnight at 4 °C.
Following overnight incubation cells, were washed then incubated with anti-mouse IgG-κ Fc binding protein
CFL 488 diluted 1:2000 in 3% BSA for 1 h at RT. After 3 washes, cells were incubated with 5 µg/mL Hoechst
33,342 in PBS for 10 min at RT. Hoechst 33,342 solution was then removed after 10 min and cells were imaged
in PBS by confocal microscopy on a Nikon A1Rsi confocal microscope. Nuclear regions of interest (ROIs) were
identified in an automated fashion by Hoechst 33,342 staining, and cytosolic regions were identified by manual
placement of ROIs within the cell outside of the nucleus. All ROI analysis was performed using NIS Elements
(Nikon).

pERK1/2 assay. Cells were plated at 70% confluency in 24-well plates and incubated overnight at 37 °C.
16–24 h prior to assay, cells were incubated in serum-free low glucose RPMI-1640 media supplemented with
0.1% fatty acid-free BSA (FAF-BSA) overnight at 37 °C, 5% CO2. Cells were washed once with PBS and preincubated with 200 µL KRBH containing 2.5 mM glucose for 30 min at 37 °C, 5% CO2. After 30 min, KRBH
was removed and replaced with either 200 µL KRBH containing the indicated concentrations of stimulants
and were stimulated for 10 min at 37 °C, 5% CO2. Supernatants were discarded and cells were lysed 75 µL TBS
containing 1% Triton-X100 supplemented with protease and phosphatase inhibitors (20 mM sodium fluoride,
2 mM sodium orthovanadate, 10 mM β-glycerolphosphate, and 10 mM sodium pyrophosphate). 50 μg of each
lysate was separated by SDS-PAGE on 10% acrylamide gels at 150 V for 90 min. Proteins were transferred onto
PVDF membranes in ice-cold Towbin Buffer, 10% ethanol at 100 V for 1 h. Membranes were blocked in 3% BSA
in TBST for 1 h at room temperature and then incubated with anti-ERK (1:2000) and anti-pERK (1:1000) in 3%
BSA in TBST overnight at 4 °C. Primary antibody was removed the following day, and membranes were incubated in goat anti-mouse IgG HRP (1:10,000) and goat anti-rabbit IR800 (1:10,000) in 3% BSA in TBST for 1 h
at room temperature. Chemiluminescence was detected using standard ECL reagents, and chemiluminescence
and fluorescence were imaged on Azure Biosystems Sapphire imager.
LC–MS/MS analysis of proteins. Cells were lysed using a Barocycler (5 °C, 60 cycles: 50 s at 35,000 psi

and 10 s at 1 atmospheric pressure) in 100 mM ammonium bicarbonate. Protein concentration was measured
by bicinchoninic acid (BCA) assay (Pierce) and 50 ug of total protein for each sample was precipitated with 4
volumes of cold acetone (-20 °C), and used for sample preparation as described previously55,56. Dried and C18cleaned peptides were re-suspended in 96.9% purified water, 3% acetonitrile, and 0.1% formic acid at a 1 µg/µL,
and 1µL was used for LC–MS/MS analysis in the Orbitrap Fusion Lumos mass spectrometer (Thermo Fisher
Scientific)55,57. The LC–MS/MS raw data were processed using MaxQuant (v1.6.3.3)58 for protein identification
and label-free quantitation59. MaxQuant results files were merged by matching rows based on the gene names.
Proteins marked as “contaminants”, “reverse” and “only identified by match between runs” were removed. All
LFQ values were then Log2 transformed for normalization, and samples were grouped based on deletions (control, IRBITKO or RYR2KO). Proteins identified in two replicates in at least one group (control or IRBITKO; control
or RYR2KO) were filtered for subsequent processing. Missing values were imputed using a constant (Zero-fill),
and the average L
 og2(LFQ) values for each group were then calculated. Downregulated proteins were considered as proteins with Log2(Fold-Change) < -1 and average MS/MS count ratio < 0.5, compared to control. Similarly, upregulated proteins were considered as proteins with L
 og2(Fold-Change) > 1 and average MS/MS count
ratio > 2, compared to control.

Gene ontology (GO) analysis. Proteins identified as up- or down-regulated in RyR2KO or IRBITKO cells
were analyzed for over-representation in specific cellular component, biological process, or molecular function
categories using PANTHER version 16 (http://www.pantherdb.org).60 Results for R
 yRKO cells and I RBITKO upregulated proteins were filtered at FDR < 0.05, > twofold enrichment, and a minimum of 4 proteins per category,
to exclude categories with 3 or less differentially regulated proteins. IRBITKO down-regulated proteins which
were filtered at FDR < 0.05 only, since no category had greater than twofold enrichment.

Data availability

All data needed to evaluate the conclusions in the paper are present in the paper or the supplementary materials.
The LC–MS/MS raw data are deposited in MassIVE (massive.ucsd.edu), a publicly accessible data repository,
with ID MSV000088343.
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